drugset / Trial / NCT01073228
Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is being conducted to determine the safety and effect on cognitive function of the investigational medication, EVP-6124, in individuals with mild to moderate probable Alzheimer's disease.
Timeline
- Start
- 2010-04
- Primary completion
- 2011-11
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ENCENICLINE | Small molecule | 0.3 mg | Oral |
| Comparator | ENCENICLINE | Small molecule | 1 mg | Oral |
| Comparator | ENCENICLINE | Small molecule | 2 mg | Oral |